Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chengtong Fund Management is a Chinese state-owned private equity and asset management company within the China Chengtong group. The firm focuses on fund investment, asset management, and advisory services, and is best known for managing large state-backed industrial and structural reform funds in China. Its activities center on capital allocation, state-owned enterprise reform, strategic emerging industries, and broader financial services rather than drug development or healthcare operations. Based on available information, it is not a life sciences, biotech, pharma, or healthcare company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chengtong Fund Management.